We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 361,330 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
TIDMN4P
RNS Number : 1433G
N4 Pharma PLC
24 May 2017
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------- 1. Identity of the issuer or N4 Pharma Plc the underlying issuer of existing shares to which voting rights are attached: (ii) --------------------------------------------------------------- ------------------ 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------- An acquisition or disposal of voting rights X ------------------------------------------------------------------- -------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ------------------------------------------------------------------- -------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ------------------------------------------------------------------- -------------- An event changing the breakdown of voting rights ------------------------------------------------------------------- -------------- Other (please specify): --------------------------------------------------------- -------- -------------- 3. Full name of person(s) Peel Hunt LLP subject to the notification obligation: (iii) ----------------------------------------------------------- ---------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ----------------------------------------------------------- ---------------------- 5. Date of the transaction 23/05/2017 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ---------------------- 6. Date on which issuer 24/05/2017 notified: ----------------------------------------------------------- ---------------------- 7. Threshold(s) that is/are Under 10% crossed or reached: (vi, vii) ----------------------------------------------------------- ---------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ---------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the of to the triggering triggering transaction shares transaction if possible using the ISIN CODE -------------- -------------------------- -------------------------------------------------------- Number Number Number Number of % of voting of of of shares voting rights (x) Shares Voting rights Rights -------------- ------------ ------------ ------------ --------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ------------ ------------ ------------ ------- ------------ -------- --------- Under Ordinary 7,200,622 7,200,622 10% ------------ ------------ ------------ ------- ------------ -------- --------- GB00BYW8QM32 -------------- ------------ ------------ ------------ ------- ------------ -------- --------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of voting % of voting financial date Conversion rights that rights instrument (xiii) Period (xiv) may be acquired if the instrument is exercised/ converted. -------------- ------------ -------------------------- --------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date Conversion rights instrument rights (xix, instrument (xvii) period refers to xx) (xviii) -------------- ------------ ------------ ------------ --------------------- ------------------- Nominal Delta -------------- ------------ ------------ ------------ --------------------- -------- --------- Total (A+B+C) ---------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------ -------------------------------------------------------- Under 10% ------------------------------------------ -------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) ----------------------------------------------------------------------------- Proxy Voting: ----------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- -------------- 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- -------------- 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- -------------- 13. Additional information: ------------------------------------------------------------- -------------- 14. Contact name: Paul Crispin ------------------------------------------------------------- -------------- 15. Contact telephone number: 0207 418 8988 ------------------------------------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLLLFISEEISFID
(END) Dow Jones Newswires
May 24, 2017 10:16 ET (14:16 GMT)
1 Year N4 Pharma Chart |
1 Month N4 Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions